Page last updated: 2024-08-16

sb 239063 and ranitidine

sb 239063 has been researched along with ranitidine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Crandall, DL; Deng, X; Ganey, PE; Lehman-McKeeman, LD; Lu, J; Malle, E; Roth, RA	1

Other Studies

1 other study(ies) available for sb 239063 and ranitidine

Article	Year
p38 mitogen-activated protein kinase-dependent tumor necrosis factor-alpha-converting enzyme is important for liver injury in hepatotoxic interaction between lipopolysaccharide and ranitidine. The Journal of pharmacology and experimental therapeutics, 2008, Volume: 326, Issue:1 Topics: ADAM Proteins; ADAM17 Protein; Animals; Enzyme Activation; Imidazoles; Lipopolysaccharides; Liver; Male; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyrimidines; Ranitidine; Rats; Rats, Sprague-Dawley	2008

Article

Year

p38 mitogen-activated protein kinase-dependent tumor necrosis factor-alpha-converting enzyme is important for liver injury in hepatotoxic interaction between lipopolysaccharide and ranitidine.

The Journal of pharmacology and experimental therapeutics, 2008, Volume: 326, Issue:1

Topics: ADAM Proteins; ADAM17 Protein; Animals; Enzyme Activation; Imidazoles; Lipopolysaccharides; Liver; Male; p38 Mitogen-Activated Protein Kinases; Protein Kinase Inhibitors; Pyrimidines; Ranitidine; Rats; Rats, Sprague-Dawley

2008